Characterization of clinical outcomes after shorter course hypofractionated and standard-course radiotherapy for stage I-III curatively-treated Merkel cell carcinoma.
New answer by Radiation Oncologist at UTMB (December 24, 2025)
Nope. There is no joy in chasing these around. The next port of call could well be an out-of-field nodal recurrence or a DM. Incidentally, there is a disproportionately high i...